Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer

/PRNewswire/ -- Angiex, developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, has appointed Marty J. Duvall as chief...

Related Keywords

Martyj Duvall ,Paul Jaminet , ,Angiex Founder ,President Paul Jaminet ,Orbimed Advisors ,Angiex Inc ,